A Cost Analysis of Non-Invasive Blood-Based microRNA Testing Versus CT Scans for Follow-Up in Patients With Testicular Germ Cell Tumors

Clinical Genitourinary Cancer - United States
doi 10.1016/j.clgc.2019.03.015

Related search